companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Check company
  • Find owner
  • Financial data
  • Credit rating

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Statstidende
  • Guides
  • Compare alternatives

Integrations

  • API
  • Zapier
  • Dinero
  • e-conomic

Legal

  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 companydata.dk

Mads Nikolaj Behrndt-Eriksen

PersonUnit number: 4008401087
København Ø
1
Ownership
2
Board positions
2
Director positions
1
Other roles
29
People in network

People in network(29)

People who held roles at the same companies, or who co-own the same companies

Johan Henrik Faber
Ebumab Holding ApS, Ebumab Holding ApS, Hemab ApS, Cymab ApS, Cymab ApS
Hans Heugh Wandall
Ebumab Holding ApS, Ebumab Holding ApS, Cymab ApS
Thomas Dal Stenfeldt Batchelor
Ebumab Holding ApS, Hemab ApS, Cymab ApS

Ownership(1)

Mabe Invest ApS
CVR: 41258993
EJERREGISTER
100%
Ownership
Active

Board positions(2)

Ebumab Holding ApS
CVR: 39807556
BESTYRELSESMEDLEM
Active
Since 1. sep. 2023
Cymab ApS
CVR: 39859173
BESTYRELSESMEDLEM
Active
Since 17. apr. 2023

Director positions(2)

Hemab ApS
CVR: 40837590
DIREKTØR
Active
Since 1. sep. 2021
Mabe Invest ApS
CVR: 41258993
DIREKTØR
Active
Since 24. mar. 2020

Other roles(1)

Mabe Invest ApS
CVR: 41258993
STIFTERE
Active
Since 24. mar. 2020

Indirect ownership(3)

Companies owned indirectly through ownership chains.

Ebumab Holding ApS
CVR: 39807556
5-9,99%
Effective ownership
Depth: 1
Ownership path:
Mabe Invest ApS(100%)
→Ebumab Holding ApS(5-9,99%)
Cymab ApS
CVR: 39859173
5-9,99%
Effective ownership
Depth: 2
Ownership path:
Mabe Invest ApS(100%)
→Ebumab Holding ApS(5-9,99%)
→Cymab ApS(100%)
Ebumab Sandbox ApS
CVR: 43575627
5-9,99%
Effective ownership
Depth: 2
Ownership path:
Mabe Invest ApS(100%)
→Ebumab Holding ApS(5-9,99%)
→Ebumab Sandbox ApS(100%)